Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Chicago, IL
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Bethesda, MD
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Kansas City, MO
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
New York, NY
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Durham, NC
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Columbus, OH
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Philadelphia, PA
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Seattle, WA
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated:  11/18/2015
mi
from
Parkville,
A Phase 2, Multicenter Study in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
A Phase 2, Multicenter, Single-arm Study of Moxetumomab Pasudotox in Pediatric Subjects With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma of B-cell Origin
Status: Enrolling
Updated: 11/18/2015
mi
from
Parkville,
Click here to add this to my saved trials
Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
CC-5013 Alone or in Combination With Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated:  11/18/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
CC-5013 Alone or in Combination With Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Status: Enrolling
Updated: 11/18/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Geriatric Assessments in Senior Adults With Multiple Myeloma
Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma
Status: Enrolling
Updated:  11/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Geriatric Assessments in Senior Adults With Multiple Myeloma
Pilot Study of Geriatric Assessments in Senior Adults With Multiple Myeloma
Status: Enrolling
Updated: 11/19/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/19/2015
Duke University
mi
from
Durham, NC
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/19/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated:  11/19/2015
Medical University of South Carolina
mi
from
Charleston, SC
Safety, Tolerability Study of SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
An Open-Label, Phase 1/Phase 2 Study to Evaluate the Safety, Tolerability, and Antitumor Activity of the DNA Minor Groove Binding Agent SG2000 in the Treatment of Advanced Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
Status: Enrolling
Updated: 11/19/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens National Medical Center
mi
from
Washington,
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Dana Farber
mi
from
Boston, MA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
St. Jude
mi
from
Memphis, TN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
St. Jude
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Vanderbilt Children's Hospital
mi
from
Nashville, TN
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Vanderbilt Children's Hospital
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Primary Children's
mi
from
Salt Lake City, UT
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Primary Children's
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Seattle Children's Hospital
mi
from
Seattle, WA
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
University of Miami Cancer Center
mi
from
Miami, FL
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
University of Miami Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated:  11/20/2015
New York Univ. Medical Center
mi
from
New York, NY
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies
A Phase I Dose Finding Study Of Panobinostat In Children With Refractory Hematologic Malignancies
Status: Enrolling
Updated: 11/20/2015
New York Univ. Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Children's Hospital of Orange County
mi
from
Orange, CA
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Children's Hospital of Orange County
mi
from
Orange, CA
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
UCSF School of Medicine
mi
from
San Francisco, CA
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
The Children's Hospital, University of Colorado
mi
from
Aurora, CO
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
The Children's Hospital, University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Childrens National Medical Center
mi
from
Washington,
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Children's Healthcare of Atlanta/Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Lurie Children's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Johns Hopkins University
mi
from
Baltimore, MD
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Dana Farber
mi
from
Boston, MA
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Dana Farber
mi
from
Boston, MA
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
C.S Mott Children's Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Childrens Hospital & Clinics of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Children's Hospital New York-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Levine Children's Hospital at Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Rainbow Babies
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated:  11/20/2015
St. Jude
mi
from
Memphis, TN
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL and POETIC
Status: Enrolling
Updated: 11/20/2015
St. Jude
mi
from
Memphis, TN
Click here to add this to my saved trials